Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease
Clinical trial NCT03415867 · UNKNOWN
Trial details
- NCT number
- NCT03415867
- Sponsor
- Grupo Espanol de trasplantes hematopoyeticos y terapia celular
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-09
- Primary completion
- 2022-01-09
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.